Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Nanomedicine
cancer
chemotherapy
drug delivery
nanomaterials in cancer.
theranostics
Journal
Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
03
2021
accepted:
16
07
2021
pubmed:
18
9
2021
medline:
29
3
2022
entrez:
17
9
2021
Statut:
ppublish
Résumé
Early detection and accurate monitoring are two critical factors affecting the outcome of anticancer therapy. However, both these factors are affected by the limitations of conventional approaches of diagnosis and treatment. Nanomedicine has progressively offered a scientific solution in improved delivery and better diagnosis of various cancers, thus providing a targeted treatment approach. With the advances in the field, simultaneous delivery and diagnosis are becoming a reality. The present manuscript discusses various drug delivery challenges, provides the scope for theranostic nanomaterials in the diagnosis and treatment of cancer. The clinical and translational potential of theranostic nanomedicine and the future directions for further research are also presented in the manuscript.
Identifiants
pubmed: 34530703
pii: CPD-EPUB-117970
doi: 10.2174/1381612827666210916140627
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
133-150Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.